We are live on ! Find out more
OCM

Osterweis Capital Management Portfolio holdings

AUM $1.94B
1-Year Est. Return 20.77%
This Fund
S&P 500
This Quarter Est. Return
+17.55%
1 Year Est. Return
+20.77%
3 Year Est. Return
+69.82%
5 Year Est. Return
+88.03%
10 Year Est. Return
+482.02%
AUM
$1.68B
AUM Growth
+$195M
Cap. Flow
-$178M
Cap. Flow %
-10.63%
Top 10 Hldgs %
27.39%
Holding
138
New
18
Increased
36
Reduced
39
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 21.43%
2 Healthcare 14.97%
3 Industrials 9.37%
4 Financials 8.24%
5 Consumer Discretionary 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPHI
51
DELISTED
INPHI CORPORATION
IPHI
$7.73M 0.46%
48,165
-31,745
-40% -$4.46M
PODD icon
52
Insulet
PODD
$9.93B
$7.67M 0.46%
29,985
+4,205
+16% +$1.04M
VAC icon
53
Marriott Vacations Worldwide
VAC
$3.98B
$7.59M 0.45%
+55,320
New +$6.52M
RPD icon
54
Rapid7
RPD
$772M
$7.51M 0.45%
+83,290
New +$5.96M
AVLR
55
DELISTED
Avalara, Inc.
AVLR
$7.48M 0.45%
45,345
+3,095
+7% +$495K
NKTR icon
56
Nektar Therapeutics
NKTR
$2.55B
$7.22M 0.43%
28,300
-3,500
-11% -$904K
SDC
57
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$7.12M 0.42%
+596,315
New +$6.75M
BAND
58
Bandwidth Inc
BAND
$1.68B
$7.1M 0.42%
46,180
-390
-0.8% -$64.3K
META icon
59
Meta Platforms (Facebook)
META
$1.52T
$6.88M 0.41%
+25,200
New +$6.91M
EVBG
60
DELISTED
Everbridge, Inc. Common Stock
EVBG
$6.5M 0.39%
43,640
+11,390
+35% +$1.46M
AXON
61
Axon Enterprise
AXON
$48.5B
$6.42M 0.38%
52,400
+8,450
+19% +$969K
IOVA icon
62
Iovance Biotherapeutics
IOVA
$2.94B
$6.4M 0.38%
137,981
-19,770
-13% -$785K
TPTX
63
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$6.27M 0.37%
51,440
-9,420
-15% -$1.03M
CRNC icon
64
Cerence
CRNC
$402M
$5.93M 0.35%
+59,035
New +$4.4M
HASI icon
65
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.1B
$5.71M 0.34%
89,979
-3,616
-4% -$185K
ACCD
66
DELISTED
Accolade Inc
ACCD
$5.51M 0.33%
+126,670
New +$5.63M
GH icon
67
Guardant Health
GH
$22.8B
$5.14M 0.31%
39,850
+16,230
+69% +$1.87M
MKSI icon
68
MKS Inc
MKSI
$20B
$5M 0.3%
33,205
+8,545
+35% +$1.12M
RVNC
69
DELISTED
Revance Therapeutics, Inc.
RVNC
$4.96M 0.3%
174,970
-20,635
-11% -$534K
DCPH
70
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$4.78M 0.28%
83,670
+27,465
+49% +$1.63M
MRTX
71
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.65M 0.28%
+21,185
New +$4.58M
EHTH icon
72
eHealth
EHTH
$41.3M
$4.63M 0.28%
65,605
+24,745
+61% +$1.88M
AAPL icon
73
Apple
AAPL
$4.46T
$4.63M 0.28%
34,900
+1,172
+3% +$141K
ADI icon
74
Analog Devices
ADI
$189B
$3.53M 0.21%
23,885
+1,410
+6% +$187K
PG icon
75
Procter & Gamble
PG
$339B
$3.33M 0.2%
23,927
-435
-2% -$60.8K

Similar funds

Osterweis Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Osterweis Capital Management held 138 positions worth $1.68B, up 13% from $1.48B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Osterweis Capital Management withdrew a net $178M in Q4 2020, closing 11 positions and reducing 39 holdings. Its most notable exit was L3Harris, an estimated $12.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Osterweis Capital Management opened a new position in PROG Holdings worth $9.07M.

  • Osterweis Capital Management's largest Q4 2020 buy was PROG Holdings: 168,470 shares worth $9.07M.
  • Osterweis Capital Management added most to Amazon in Q4 2020, an estimated $13.8M increase.
  • Osterweis Capital Management's biggest Q4 2020 reduction was American Water Works, cutting an estimated $11.8M.
  • Osterweis Capital Management fully exited L3Harris in Q4 2020, selling an estimated $12.5M.
  • Osterweis Capital Management's ten largest holdings make up 27% of its $1.68B portfolio in Q4 2020.
  • Osterweis Capital Management opened 18 new positions and closed 11 in Q4 2020.
  • Osterweis Capital Management's portfolio value rose 13% quarter-over-quarter to $1.68B.

Based on Osterweis Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.